NCT02058628 - Comparison of the Efficacy and Safety of Clindamycin + Benzoyl Peroxide Formulation With Azelaic Acid Formulation in the Treatment of Acne Vulgaris | Biotech Hunter

Enrollment

222

Participants

Timeline

Start Date

February 21, 2014

Primary Completion Date

September 8, 2014

Study Completion Date

September 8, 2014

Conditions

Acne Vulgaris

Interventions

DRUG

Clindamycin + BPO

Gel containing 1.2% clindamycin and 3% BPO for once daily application

DRUG

Azelaic acid

Cream containing 20% azelaic acid for twice daily application

Trial Locations (11)

GSK Investigational Site, Berlin

GSK Investigational Site, Mahlow

GSK Investigational Site, Kiel

GSK Investigational Site, Magdeburg

GSK Investigational Site, Düsseldorf

GSK Investigational Site, Duelmen

GSK Investigational Site, Stuttgart

GSK Investigational Site, Tübingen

GSK Investigational Site, Gilching

GSK Investigational Site, Augsburg

GSK Investigational Site, Dessau